NCT00673608View on ClinicalTrials.gov

Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload

PHASE4CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
HemoglobinopathiesMyelodysplastic SyndromesOther Inherited or Acquired AnaemiaMPD SyndromeDiamond-Blackfan AnemiaOther Rare AnaemiasTransfusional Iron Overload
Interventions
DRUG

deferasirox

Deferasirox up to 40mg/kg/day, PO, Dispersible tablets, taken once daily

Trial Locations (4)

Unknown

Novarts Investigative Site, Adelaide

Novarts Investigative Site, Brisbane

Novarts Investigative Site, Melbourne

Novarts Investigative Site, Sydney

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY